当前位置:首页 > 化工头条

Chemours announces settlement to resolve US EPA claims on PFAS discharges

化工头条2026-07-06116
B910化工消息:July 2 - Chemours announced it has reached a settlement agreement with the United States Environmental Protection Agency (EPA) to resolve claims related to per- and polyfluoroalkyl substances (PFAS) discharges from its manufacturing facilities. The settlement addresses long-standing environmental compliance issues at Chemours production sites, including its flagship Fayetteville Works facility in North Carolina. PFAS, often referred to as forever chemicals, have been a major focus of environmental regulation in the US and globally, with increasing scrutiny on chemical manufacturers for historical and ongoing discharges. The settlement requires Chemours to implement enhanced environmental monitoring, invest in pollution control infrastructure upgrades, and provide funding for community health monitoring and environmental remediation efforts in affected areas. For the chemical industry, this settlement is significant as it sets a precedent for how PFAS-related environmental liabilities will be resolved between chemical manufacturers and US regulators. Multiple chemical companies including DuPont, 3M, and others face similar PFAS-related claims and litigation. The financial impact of PFAS remediation and settlement costs continues to weigh on chemical company balance sheets. Industry analysts noted that the Chemours settlement provides a framework for resolving PFAS environmental claims, though the total cost burden across the industry remains substantial and may take years to fully address. The settlement also reinforces the trajectory of increasingly stringent PFAS regulation globally, which is driving chemical companies to invest in PFAS alternatives and phase out production of long-chain PFAS compounds. (来源:Process Worldwide)

扫描二维码推送至手机访问。

版权声明:本文由B910化工发布,如需转载请注明出处。

本文链接:https://b910.cn/N/1731.html

标签: Array
分享给朋友:

相关文章

河北丰梵新材10万吨/年环己酮项目签约中国化学

据中国化学十三化建报道,10月27日,公司与丰梵新材料有限公司签订了10万吨/年环己酮(二期)项目和新建20万吨/年(35%wt)双氧水项目PC总承包合同,合同总金额13.15亿元。 公司党委书…

FDA 批准 Axsome 的 Auvelity 用于阿尔茨海默病激越症状,为首款 NMDA 受体靶向疗法

FDA批准Axsome Therapeutics的Auvelity(右美沙芬/安非他酮复方)用于阿尔茨海默病相关激越症状。这是首个同时靶向NMDA和sigma-1受体的该适应症疗法。审批基于ADVAN…

庄信万丰报告:2026年铂金需求将连续第四年超过供应

Johnson Matthey发布最新PGM市场报告,预计铂金市场2026年将连续第四年出现供应缺口,钌和铱也将供不应求。数据中心建设推动铂金和钌需求,欧洲两个大型绿氢项目完工将拉动铱需求。霍尔木兹海…

FDA 为三种致幻剂药物发放优先审评券

FDA 向 Compass Pathways、Usona Institute 和 Transcend Therapeutics 三家公司发放优先审评券,加速审查其用于精神健康领域的致幻剂药物。涉及的药…

Transition Industries在墨西哥启动太平洋甲醇项目

Transition Industries在墨西哥Topolobampo举行Pacífico Mexinol项目奠基仪式。该项目投资超33亿美元,建成后将成为全球最大超低碳化学品设施,年产约180万吨…

Ba₁₋ₓSrₓTiO₃组分调控实现低温余热高效收集,1万次循环稳定运行

研究团队在Ba₁₋ₓSrₓTiO₃中发现过渡区组分Sr₀.₁₉实现最优热电能量收集性能,在64°C下达到1.6 mJ/cm³能量密度和5.5%转化效率,无外加偏置电场下稳定运行超过1万次循环。…